LUTZ GIEBEL
Profile
First Name
Middle Name
Last Name
Related Companies
Titles
Company Name
Related People
DIRECTOR
EDDY ANGLADE,
A. CLARKE ATWELL,
AXEL BOLTE,
PAUL CHANEY,
PAUL G. CHANEY,
THOMAS DYRBERG,
GEORGE ELDRIDGE,
ULRICH M. GRAU,
DAVID GUYER,
DEAN MITCHELL,
DEAN J MITCHELL,
DAVID SCHNELL,
BRETT SKOLNIK
DIRECTOR
METTE KIRSTINE AGGER,
ROBERT M BRENNER,
ROBERT M. BRENNER,
SCOTT CANUTE,
THOMAS DRYBERG,
THOMAS DYRBERG,
GEORGE ELDRIDGE,
DAVID GUYER,
KEVIN J. HEYECK,
CHRISTOF WESTENFELDER,
JOHN WIRTHLIN,
JOHN B. WIRTHLIN
DIRECTOR
THOMAS BIANCARDI,
ALEX BOLTE,
AXEL BOLTE,
DAVID CARROLL,
THOMAS DYRBERG,
NICHOLAS GALAKATOS,
DAVID GUYER,
EVELYN HARRISON,
JANE PRITCHETT HENDERSON,
SAMIR C. PATEL,
BRUCE PEACOCK,
DAVID REDLICK,
MICHAEL ROSS,
GLENN SBLENDORIO,
HENRY SIMON,
KEITH WESTBY
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity, Debt
2021-09-29
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
2013-03-15
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
2012-12-24
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
2012-06-20
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2012-03-29
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2012-03-16
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2012-02-23
D/A
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2010-12-10
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2011-12-05
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2011-09-30
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2011-06-30
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2011-03-03
D
BIOTECHNOLOGY
NO REVENUES
Debt
2010-12-03
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2010-05-14
D
PRIVATE EQUITY FUND
NOT APPLICABLE
2010-03-26
D/A
PRIVATE EQUITY FUND
NOT APPLICABLE
2009-03-27
D
BIOTECHNOLOGY
NO REVENUES
Equity
2009-11-05
D
BIOTECHNOLOGY
NO REVENUES
Equity
2009-10-15
D/A
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2007-06-11
D
BIOTECHNOLOGY
NO REVENUES
Debt
2009-06-25
D
BIOTECHNOLOGY
NO REVENUES
Debt
2009-06-03
